GlassScriptPhysician profile
Michael B Hurwitz
NPI 1437179595
$9,712.68
in general payments reported to CMS, 2019-2025
11 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,181 · 2020: $621 · 2021: $122 · 2022: $139 · 2023: $531 · 2024: $2,881 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Education: $1,500 · Travel and Lodging: $234 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.45 |
| Education | $1,500.00 |
| Travel and Lodging | $233.73 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,552.75 | 2019-2024 | Da Vinci Surgical System |
| Covidien LP | $2,433.35 | 2019 | |
| Davol INC. | $966.24 | 2020-2024 | Phasix Mesh, Arista Ah Flexitip |
| Becton, Dickinson and Company | $357.60 | 2023-2024 | Phasix Mesh |
| Boston Scientific Corporation | $116.64 | 2025 | Axios |
| Bard Access Systems, INC. | $75.66 | 2019 | |
| Baxter Healthcare | $55.62 | 2025 | Perclot |
| Conmed Corporation | $53.62 | 2019 | |
| Tela Bio, INC. | $53.30 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $28.73 | 2025 | Progrip |
| Shire North American Group INC | $19.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hurwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.